Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05650879
Title ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer (HER2)
Acronym HER2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Enliven Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | AUS

Additional content available in CKB BOOST